Get details about our clinical trials that are currently enrolling patients.View Clinical Trials
MD Anderson is my hope. I know that without it, I wouldn’t be alive today.
Using a comprehensive team approach, we work together to give you customized care that includes the most advanced diagnostic methods and treatments.
As a foremost treatment program for leukemia, we offer access to numerous innovative new therapies and investigational agents that may help increase your chances for successful treatment. Many of these are not found in other centers. We have the full range of services needed to ensure comprehensive, yet specialized care.
Care Designed Specifically for You
Successful leukemia treatment begins with accurate and precise diagnosis. As many as 15% of leukemia patients have been misdiagnosed before they come to MD Anderson. We have the expertise and experience gained from being one of the most active programs in the world, and our specialized pathologists are highly experienced in diagnosing leukemia.
Our approach to leukemia is customized especially for you; we do not take a one-size-fits-all approach. Our first step is to carefully evaluate your risk factors to determine if treatment is necessary. If it is, we recommend the most advanced therapy with the least impact on your body.
Whether you are treated as an inpatient or outpatient, our comprehensive program offers all the services needed to care for leukemia and its impact on your body, such as infections and bleeding issues. We strive to accomplish as much care as possible on an outpatient basis. Because we know your time is valuable, we offer a complete on-site lab and “fast track” clinic for timely and efficient outpatient care. If hospitalization is needed, our expert staff is specially trained to take care of complexities that may arise.
Researching the Future
MD Anderson is known internationally for developments in the treatment of leukemia. In fact, we have helped pioneer many treatments, including decitabine (Dacogen®), dasatinib (Sprycel®), nilotinib (Tasigna®), imatinib mesylate (Gleevec) and clofarabine (Clolar®).
And we are constantly striving to find new and better ways to fight leukemia. We are one of the few cancer centers in the nation to house a prestigious federally funded SPORE (Specialized Program of Research Excellence) program. This means we are able to offer a wide range of clinical trials for leukemia treatment.
Understanding a disease is the first step toward finding the right care. Get the facts about leukemia, including the different types, how it starts and who’s at risk.
Did you know?
August 25, 2016
Lea White is a survivor in every sense of the word. The U.S. Marines veteran left home at age 16 and developed a stubborn determination to overcome adversity along the way.
She’d just gotten a divorce, moved to California, suffered the loss of two pets and was drowning in work when life dealt her another blow: an acute myelogenous leukemia (AML) diagnosis in April 2004.
“I’ve always been a survivor, and so this was just...
Moon Shots Program
MD Anderson’s MDS/AML Moon Shot™ and CLL Moon Shot™ aim to rapidly and dramatically improve treatment outcomes for leukemia patients through powerful new treatment approaches and research.Learn more about the Moon Shots Program